◂ Announcements

Mar 30, 2021ACQUISITIONBelgium

Sino Biopharmaceutical acquires Softhale for US$110 million

Sino Biopharmaceutical Ltd, through its subsidiary invoX Pharma Ltd, acquired 100% of Softhale NV for US$110 million plus additional milestone payments. Softhale is a Belgian company developing respiratory disease treatments and a Soft Mist Inhalation device.

Value

$110.0M

Status

Announced

ProductsSoft Mist Inhalation devicerespiratory disease treatments

CompaniesSino Biopharmaceutical acquirer Softhale target

Sectors#Medical Devices

“invoX Pharma Ltd, a wholly-owned subsidiary of the Company, entered into an agreement in relation to a 100% acquisition of SOFTHALE NV for US$110 million and additional payments related to regulatory and commercial milestones.”softhale.com

1 source
softhale.comSino Biopharmaceutical Ltd acquires Softhale - SofthaleMar 30, 2021

Summarized from public sources; check the original articles before acting on it.

Similar announcements

Nov 6, 2026ACQUISITIONUnited States$9.90B
Danaher to acquire Masimo for $9.9 billion
Danaher acquirer Masimo target mdtvnow.com
Nov 5, 2026ACQUISITIONUnited States
Curewell Capital to acquire majority stake in ECA Medical
Curewell Capital acquirer ECA Medical target businesswire.com
Nov 5, 2026ACQUISITIONUnited States$538.0M
ZOLL Medical to acquire Itamar Medical for $538M
Asahi Kasei investor ZOLL Medical Corporation acquirer forpressrelease.com
Nov 4, 2026ACQUISITIONPlano, Texas, United States$2.25M
OSTEONIC acquires controlling stake in FoxEyes for 3 billion won
OSTEONIC FoxEyes target en.edaily.co.kr
Nov 3, 2026ACQUISITIONDeerfield, Illinois, United States
Vantive to divest majority of hemodialysis assets to Rockwell Medical
Vantive Rockwell Medical acquirer prnewswire.com
Nov 3, 2026ACQUISITIONMedolla, Italy, Italy$125.0M
Rockwell Medical to acquire Vantive's hemodialysis business for $400-450M annual revenue
Rockwell Medical acquirer Vantive target sec.gov nasdaq.com securities.io

Loading…